AMGN vs REGN
By Alex · Tickerpine
Amgen Inc. vs Regeneron Pharmaceuticals, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | REGN |
|---|---|---|
| Price | $416.18 | $797.99 |
| Market cap | $225.15B | $82.16B |
| P/E ratio | 25.7 | 19.7 |
| ROE | 91.47% | 14.04% |
| Profit margin | 22.95% | 27.87% |
| Revenue growth | 9.50% | 16.70% |
| Dividend yield | 2.43% | 0.47% |
| Beta | 0.41 | 0.19 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs REGN in plain English
- AMGN is the bigger company — about 2.7× the market cap of REGN.
- REGN is cheaper on earnings (P/E 19.7 vs 25.7).
- AMGN earns a higher return on equity (91% vs 14%).
- REGN is growing revenue faster (17% vs 10%).
- AMGN has the higher dividend yield (2.43% vs 0.47%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
REGN return calculator
See what $1,000 in Regeneron Pharmaceuticals, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.